This inventor holds 1 USPTO granted patent. Top assignee: Aventis Behring Gmbh. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Austin Smith - Innovator in Transgenic Research
Introduction
Austin Smith is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of biomedical research, particularly in the area of coagulation factors and wound healing.
Latest Patents
Austin Smith holds a patent for a transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding. This invention provides a transgenic mouse that is heterozygous or homozygous for an at least partially defective coagulation factor XIII gene. This innovative approach has the potential to enhance the understanding of wound healing processes and bleeding disorders.
Career Highlights
Austin Smith is currently employed at Aventis Behring GmbH, where he continues to advance research in his field. His work has been instrumental in developing new methodologies for testing and understanding coagulation factors.
Collaborations
Austin has collaborated with esteemed colleagues such as Gerhard Dickneite and Hubert Metzner, contributing to a rich environment of innovation and research.
Conclusion
Austin Smith's work in transgenic research exemplifies the impact of innovative thinking in the biomedical field. His contributions are paving the way for advancements in understanding and treating bleeding disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile